Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
1.960
-0.040 (-2.00%)
At close: May 20, 2024, 3:57 PM
1.990
+0.030 (1.53%)
After-hours: May 20, 2024, 7:55 PM EDT

Alterity Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for ATHE stock have an average target of 7.00, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 257.14% from the current stock price of 1.96.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $4.00 $7.00 $10 $10
Change +104.08% +257.14% +410.20% +410.20%
* Price targets were last updated on Mar 7, 2024.

Analyst Ratings

The average analyst rating for ATHE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 11111
Buy 00111
Hold 00000
Sell 00000
Strong Sell 00000
Total 11222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Benchmark
Benchmark
Buy
Reiterates
$4
Buy Reiterates $4 +104.08% Mar 7, 2024
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Maintains
$20$10
Strong Buy Maintains $20$10 +410.20% Jun 5, 2023
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Initiates
$20
Strong Buy Initiates $20 +920.41% Aug 3, 2022
Benchmark
Benchmark
Buy
Initiates
n/a
Buy Initiates n/a n/a Aug 20, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.